U.S. Markets closed

Global Anti-Infective Vaccine Market - Forecast to Grow 5.88% by 2021 - Driven by Rising Technological Development in Vaccine Industry - Research and Markets

DUBLIN, Mar 03, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Anti-Infective Vaccines Market - Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)" report to their offering.

Research and Markets Logo

The Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over 5.88% during 2016-2021.

Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines. Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.

Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO's.

Companies Mentioned

  • Astrazeneca
  • CSL Limited
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Merck & Co. Inc.
  • Pfizer
  • Protein Sciences Corporation 
  • Sanofi Pasteur Inc.
  • Serum Institute Of India Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation

4. Global Anti-infective Vaccines Market: Product Overview

5. Global Anti-infective Vaccines Market: Growth and Forecast

6. Global Anti-Bacterial Vaccines Market: Growth and Forecast

7. Global Anti-Viral Vaccines Market: Growth and Forecast

8. Global Anti-infective Vaccines Market - By Disease

9. Global Anti-Infective vaccines- Pipeline Analysis

10. North America Anti-infective Vaccines Market: Sizing and Growth

11. North America Anti-Infective Vaccines Market- By Disease

12. Europe Anti-Infective Vaccines Market: Sizing and Growth

13. Europe Anti-Infective Vaccines Market- By Disease

14. APAC Anti-Infective Vaccines Market: Sizing and Growth

15. APAC Anti-Infective Vaccines Market- By Disease

16. ROW Anti-Infective Vaccines Market 

17. Market Dynamics

18. Policy and Regulatory Landscape

19. Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/kxkc8m/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-anti-infective-vaccine-market---forecast-to-grow-588-by-2021---driven-by-rising-technological-development-in-vaccine-industry---research-and-markets-300417632.html